The more useful question is whether the total cost over 1 month includes the clinician visit, medication, shipping, labs, refills, and follow-up
You dont need insurance to access weight loss treatment through Mochi
Heterogeneity of Renal Endpoints and Implications A major source of heterogeneity across the evidence base relates to the definition and reporting of renal outcomes
Current GLP-1 medications remain appropriate first-line options
This 72-week multicenter, randomized, double-blind, placebo-controlled study included 320 middle-aged obese patients with biopsy-proven NASH (mean age: 55 years
Those who were already treated with an additional glucose-lowering drug (or several) at the beginning of combination therapy were included if (and when) the additional medication was halted and the individual thus received only a combination of metformin and GLP-1 RA or metformin and DPP-4i treatment